EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice

Renzo Mignani iD, Elena Biagini, Vittoria Cianci, Federico Pieruzzi, Antonio Pisani, Antonino Tuttolomondo, Maurizio Pieroni

Advances in Therapy · 2025

DOI: 10.1007/s12325-024-03041-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Therapy, 2025. Verfasst von Renzo Mignani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation, IRCCS S. Orsola Hospital Bologna, University of Bologna, Bologna, Italy. renzo.mignani2@unibo.it. Hauptthemen laut MEDLINE: Fabry Disease, alpha-Galactosidase, Enzyme Replacement Therapy, 1-Deoxynojirimycin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi Italia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry Diseasealpha-GalactosidaseEnzyme Replacement Therapy1-DeoxynojirimycinHumansQuality of LifeDisease ProgressionIsoenzymesRecombinant Proteins

Stichwörter der Autor:innen

Agalsidase alfaAgalsidase betaCardiovascular outcomesEnzyme replacement therapyFabry diseaseNeurological outcomesPegunigalsidase alfaQuality of lifeRenal outcomes

Substanzen

alpha-Galactosidasemigalastat1-Deoxynojirimycinagalsidase alfaagalsidase betaIsoenzymesRecombinant Proteins

Autor:innen und Institutionen

  • Nephrology, Dialysis and Transplantation, IRCCS S. Orsola Hospital Bologna, University of Bologna, Bologna, Italy. renzo.mignani2@unibo.it.
  • Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart), Bologna, Italy.
  • Neurology, Great Metropolitan Hospital, Reggio Calabria, Italy.
  • Clinical Nephrology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

ORCID-Profile: Renzo Mignani

Förderung

  • Sanofi Italia

Zitieren

APA

Mignani, R., Biagini, E., Cianci, V., Pieruzzi, F., Pisani, A., Tuttolomondo, A., & Pieroni, M. (2025). Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice. Advances in Therapy. https://doi.org/10.1007/s12325-024-03041-2

Vancouver

Mignani R, Biagini E, Cianci V, Pieruzzi F, Pisani A, Tuttolomondo A, et al. Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice. Advances in Therapy. 2025. doi:10.1007/s12325-024-03041-2

BibTeX
@article{Mignani2025,
  author = {Mignani, Renzo and Biagini, Elena and Cianci, Vittoria and Pieruzzi, Federico and Pisani, Antonio and Tuttolomondo, Antonino and Pieroni, Maurizio},
  title = {Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice},
  journal = {Advances in Therapy},
  year = {2025},
  doi = {10.1007/s12325-024-03041-2}
}
Kostenlos starten →